HCA Healthcare
HCA
439.17
+6.97
+1.61%
HCA Healthcare
US · HCA
#238 by market cap
Listed 1970
439.17
+6.97
+1.61%
Live - 5344 symbols - heartbeat 422s ago
· 2026-10-08 07:21
Pre-market
443.00
+0.87%
After-hours
439.22
+0.01%
Overnight
439.17
0.00%
- Market cap
- 95.08B
- P/E (TTM)i
- 14.73
- P/Bi
- -14.32
- EPSi
- 28.33
- Div yieldi
- 0.68%
- 52W posi
- 43%
Reader sentiment
Are you bullish or bearish on HCA?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Accumulating
- The number of reporting institutions decreased by 11 in the most recent period (2026/Q3).
- Total institutional ownership rose 0.4 percentage points.
Institutional ownership
- Held by institutions
- 94.57% +0.39pp
- Institutions
- 1,623 -11
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund52.11%
Private Company32.98%
Hedge Fund2.99%
Public Company2.69%
Government Pension Fund1.85%
Individual/Insider1.43%
Sovereign Wealth Fund1.04%
Insurance Company0.26%
Family Office/Trust0.21%
Other4.43%
Top holders as of 2026-04-28
Frisco Holding II
16.89% · 36.56M sh
Hercules Holding Ii, LLC
14.91% · 32.28M sh
BlackRock
6.01% · 13.00M sh
Vanguard Capital Management, LLC
5.09% · 11.01M sh
Sanders Capital, LLC
4.08% · 8.83M sh
Other
53.03%
State Street Global Advisors
3.45% · 7.47M sh
Wellington Management Group
2.17% · 4.71M sh
Capital Research
1.80% · 3.89M sh
Geode Capital Management, LLC
1.69% · 3.67M sh
First Eagle Investment Management, LLC
1.52% · 3.30M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 22 buys · 23 sells
| Name | Role | Stake |
|---|---|---|
| Frisco Holding II | -- | 16.89% |
| Hercules Holding Ii, LLC | -- | 14.91% |
| Samuel Hazen | Chief Executive Officer | 0.65% |
| Thomas Frist | Former Chairperson | 0.22% |
| William Frist | Director | 0.19% |
| William Rutherford | Chief Financial Officer | 0.09% |
| Jon Foster | Chief Operating Officer | 0.09% |
| Michael Marks | Officer | 0.03% |
| Christopher Wyatt | Senior Vice President | 0.02% |
| Michael Cuffe | Executive VP & Chief Clinical Officer | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-31 | Michael Schlosser | Senior Vice President of Care Transformation & Innovation | Initial Statement of Beneficial | 0 | -- |
| 2026-08-25 | Michael McAlevey | Chief Legal Officer | Other Disposition | -7,769 | $429.00 |
| 2026-05-06 | Michael Marks | Officer | Other Acquisition | +3,336 | -- |
| 2026-05-06 | Michael Marks | Officer | Other Disposition | -3,336 | -- |
| 2026-04-27 | John Chidsey | Independent Director | Other Acquisition | +809 | -- |
| 2026-04-27 | Michael Michelson | Independent Director | Other Acquisition | +925 | -- |
| 2026-04-27 | Nancy-Ann DeParle | Independent Director | Other Acquisition | +509 | -- |
| 2026-04-27 | Thomas Frist | Chairperson | Other Acquisition | +1,041 | -- |
| 2026-04-27 | Hugh Johnston | Independent Director | Other Acquisition | +809 | -- |
| 2026-04-27 | Wayne Riley | Independent Director | Other Acquisition | +509 | -- |
| 2026-04-27 | William Frist | Director | Other Acquisition | +809 | -- |
| 2026-04-27 | Andrea Smith | Independent Director | Other Acquisition | +509 | -- |
| 2026-02-17 | Michael McAlevey | Chief Legal Officer | Derivative Exercise and Sale | -5,000 | $236.61–540.29 |
| 2026-02-17 | Michael McAlevey | Chief Legal Officer | Intent to Sell (Form 144) | -1,694 | $533.34 |
| 2026-02-10 | Christopher Wyatt | Senior Vice President | Open Market Disposition | -4,000 | $505.00 |
| 2026-02-10 | Jennifer Berres | Chief Human Resources Officer | Open Market Disposition | -8,020 | $503.00–526.16 |
| 2026-02-09 | Samuel Hazen | Chief Executive Officer | Sale to Issuer | -21,323 | $502.05 |
| 2026-02-09 | Samuel Hazen | Chief Executive Officer | Other Acquisition | +54,934 | -- |
| 2026-02-09 | Michael McAlevey | Chief Legal Officer | Sale to Issuer | -3,006 | $502.05 |
| 2026-02-09 | Michael McAlevey | Chief Legal Officer | Other Acquisition | +8,372 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:21:18 · For reference only, not investment advice and not tailored to your situation.